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Abstract
Background: The melanocortin 1 receptor gene (MC1R) is responsible for normal pigment
variation in humans and is highly polymorphic with numerous population-specific alleles. Some
MC1R variants have been associated with skin cancer risk.
Results: Allele frequency data were compiled on 55 single nucleotide polymorphisms from seven
geographically distinct human populations (n = 2306 individuals). MC1R nucleotide diversity, π, was
much higher (10.1 × 10-4) than in other genes for all subjects. A large degree of population
differentiation, determined by FST, was also present, particularly between Asia and all other
populations, due to the p.R163Q (c.488 G>A) polymorphism. The least amount of differentiation
was between the United States, Northern Europe, and Southern Europe. Tajima's D statistic
suggested the presence of positive selection in individuals from Europe.
Conclusion: This study further quantifies the degree of population-specific genetic variation and
suggests that positive selection may be present in European populations in MC1R.
Background
Differences in human skin pigmentation have been attrib-
uted to genetic variation in several different genes [1-3].
Among these, the melanocortin 1 receptor gene (MC1R,
MIM#155555), a member of the G protein-coupled recep-
tors superfamily, is the major contributor to normal pig-
ment variation in humans. It is a small, highly
polymorphic gene consisting of one exon with 951 coding
nucleotides on chromosome 16q24.3.
Numerous studies have demonstrated associations
between specific MC1R variants and red hair, light skin,
poor tanning ability and heavy freckling [4-9]. A recent
genome-wide association scan confirmed the role of
MC1R SNPs in hair, eye, and skin pigmentation[3]. The
functional role of many of these variants has been
described [10-13]. Several MC1R variants are also associ-
ated with increased risk of malignant melanoma in a vari-
ety of populations [14-22] The effect of MC1R
polymorphisms in melanoma risk appears to extend
Published: 10 April 2008
BMC Genetics 2008, 9:31 doi:10.1186/1471-2156-9-31
Received: 1 November 2007
Accepted: 10 April 2008
This article is available from: http://www.biomedcentral.com/1471-2156/9/31
© 2008 Savage et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Genetics 2008, 9:31 http://www.biomedcentral.com/1471-2156/9/31
Page 2 of 8
(page number not for citation purposes)
beyond its effect on pigmentation in most of these inves-
tigations, and to be linked to melanomas harboring muta-
tions in the BRAF oncogene[23].
Several hypotheses have been generated in an effort to
understand the evolutionary history of skin pigmentation
in humans. It has been suggested that as humans migrated
out of Africa to climates with more limited exposure to
sunlight, relaxation of functional constraints in pigmenta-
tion genes, including MC1R, or selection for functionally
relevant variants that led to lighter skin pigmentation
occurred[24]. This could result in an improved ability to
synthesize vitamin D in the presence of limited sunlight
exposures [25-27]. It has also been suggested that darker
skin is favored in regions closer to the equator for protec-
tion against ultraviolet radiation[24]. In addition, differ-
ences in skin pigmentation could protect against
pathogens and cold injury, and may have also been
important in sexual selection[28].
Genetic variation of MC1R, in the form of single nucle-
otide polymorphisms (SNPs), is significantly different
across populations from different geographic regions
[29,30]. In most regions of the genome, there is a higher
degree of genetic variation in individuals of African
descent than in other populations, most likely due to evo-
lutionary history [31,32]. MC1R is an exception to this
observation. It has been shown to be more polymorphic
in individuals of European descent than in those from
Africa [29,30]. A comprehensive study of SNP allele fre-
quencies in MC1R from populations around the world,
further quantified the large differences in the distribution
of variants across populations, with a prominent differ-
ence between light and dark-pigmented individuals [29].
The goal of the current study was to expand on that study
of MC1R genetic variation by characterizing nucleotide
diversity, population specific differentiation (FST), and to
study measures of selection.
Results
Nucleotide Diversity
Allele frequency (AF) data was compiled from a total of
2306 individuals who were grouped into seven popula-
tions, based on geographic location (Table 1). The actual
number of individuals in each group was Africa 117, India
53, Southern Europe 838, Northern Europe 650, Asia 343,
Papua New Guinea 40, and the United States 265. The
number of SNPs per population evaluated in the study
ranged from three (India) to 36 (Southern Europe), with
a total of 55 SNPs studied in MC1R in these analyses. AFs
are shown in Table 2. Thirty-seven SNPs were nonsynon-
ymous (NS) and 18 were synonymous (S). The greatest
number of SNPs was present in individuals from Southern
Europe (29 NS, 7 S) and Northern Europe (18 NS and 3
S). The fewest number of SNPs were noted in the subjects
from India (2 NS, 1 S), Papua New Guinea (2 NS, 2 S) and
Africa (3 NS and 8 S).
In order to correct for the variable population sizes, which
could contribute to the absolute number of SNPs identi-
fied, π and θ, measures of nucleotide diversity, were calcu-
lated. The overall nucleotide diversity for all SNPs in
MC1R, as measured by π, was 10.1 × 10-4 for all popula-
tions (2306 total subjects); it ranged from a low of 3.6 ×
10-4 in subjects from India to a high of 11.1 × 10-4 from US
subjects (Table 3). In subgroup analyses of the Northern
and Southern European populations, π was the highest in
subjects from Britain (18.1 × 10-4).  θ, the population
mutation parameter, was quite variable across popula-
tions, ranging from 6 × 10-4 in India to 47.3 × 10-4 in
Southern Europe. In Southern European subjects, θ was
the highest, 43.6 × 10-4, in Italy.
Table 1: Description of populations and studies used for analyses of MC1R allele frequencies
Population Name Description # Individuals Reference
Africa Healthy subjects from South Africa (22 Negroid and 17 San 
people), 25 from South Africa, Nigeria, Zaire, Kenya and 
Gambia, and 53 from The Ivory Coast and Gambia
117 John 2003, Rana 1999, Harding 2000
India Healthy subjects from studies investigating MC1R variants. 53 Rana 1999, Harding 2000
Southern Europe Healthy subjects from Spain (188), Italy (495) and Greece (155) 838 Fernandez 2007, Harding2000, Fargnoli 
2003, Pastorino 2004, Landi 2005, 
Fargnoli 2006, Stratigos 2006,
Northern Europe Healthy subjects from The Netherlands (385), Britain/Ireland 
(93) and France (172)
650 Bastiaens 2001, Kennedy 2001, Flanagan 
2000, Harding 2000, Chaudru 2005
Asia Healthy subjects from East and Southeast Asia. Rana et al 
reported individuals from China (50), Japan (4), Cambodia (1), 
Vietnam (1), Siberian Yakut (5) and Mongolia (4). The remaining 
studies were of individuals from Japan.
343 Rana 1999, Harding 2000, Motokawa 
2006, Nakayama 2006
Papua New Guinea Healthy subjects from studies investigating MC1R variants. 40 Harding 2000, Nakayama 2006
United States Healthy Caucasian subjects participating in a population based 
study conducted in Philadelphia, PA and Caucasian spouse 
controls from the US in a familial melanoma case/control study.
265 Kanetsky 2004, Goldstein 2005BMC Genetics 2008, 9:31 http://www.biomedcentral.com/1471-2156/9/31
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Table 2: Allele frequencies (%) of MC1R single nucleotide polymorphisms in seven populations. 
protein nucleotide All subjects Africa Asia India NoEur SoEur US PNG
p.P18A c.52 C>G 0 0 0 0 0.08 0 0 0
p.C35Y c.104 G>A 0 0 0 0 0 0.12 0 0
p.V38M c.112 G>A 0 0 0 0 0 0.06 0 0
p.L44V c.130 C>G 0 0 0 0 0 0.06 0 0
p.F45L c.133 T>C 0 0 0 0 0 0.24 0 0
p.S47I c.140 G>T 0 0.43 0 0 0 0 0 0
p.L50L c.150 G>A 0 1.28 0 0 0 0 0 0
p.V60L c.178 G>T 0.10 0 0 0 10.69 15.75 13.21 0
p.R67Q c.200 G>A 0 0 1.17 0 0 0.06 0 0
p.A81P c.241 G>C 0 0 0 0 0.08 0 0 0
p.S83P c.247 T>C 0 0 0 0 0.15 0.12 0.19 0
p.S83L c.248 C>T 0 0 0 0 0 0.06 0 0
p.D84E c.252 C>A 0 0 0 0 1.00 0.12 1.51 0
p.V92M c.274 G>A 0.07 0 13.41 0.94 8.00 3.70 9.06 3.75
p.T95M c.284 C>T 0 0 0 0 0.08 0.12 0 0
p.L99I c.295 C>A 0 0.43 0 0 0 0 0 0
p.A103A c.309 C>T 0 0.43 0 0 0 0 0 0
p.L106Q c.317 T>A 0 0 0 0 0 0.06 0 0
L106L c.318 G>A 0 1.71 0 0 0 0.12 0 0
p.A111V c.332 C>T 0 0 0 0 0 0.18 0 0
p.I120T c.359 T>C 0 0 1.75 0 0 0.06 0 0
p.V122M c.364 G>A 0 0 0 0 0 0.24 0 0
p.V122V c.366 G>C 0 0 0 0 0 0.12 0 0
p.R142H c.425 G>A 0.01 0 0 0 0.62 1.31 0.75 0
p.R151C c. 451 C>T 0.03 0 0 0 5.62 3.16 6.42 0
p.Y152X c.456 C>A 0 0 0 0 0 0.06 0 0
p.I155T c.464 T>C 0 0 0 0 0.23 0.48 1.51 0
p.R160W c.478 C>T 0.04 0 0 0 8.31 1.85 7.17 0
p.R160Q c.479 G>A 0 0 0 0 0 0.06 0 5
p.R163Q c.488 G>A 0.14 0 75.51 4.72 4.62 1.61 4.15 0
p.A166A c.498 G>A 0 0 0 0 0 0 0 11.25
p.I168I c.504 C>T 0 0.43 0 0 0 0 0 0
p.A171D c.512 C>A 0 0 0 0 0 0.06 0 0
p.V174I c.520 G>A 0 0 0 0 0.08 0 0 0
p.Y182Y c.546 C>T 0 0 0 0 0 0 0.19 0
p.F196L c.586 T>C 0 2.14 0.15 0 0.08 0 0 0
p.R213W c.637 C>T 0 0 0 0 0 0.06 0 0
p.G220G c.660 C>T 0 0 0 0 0 0.06 0 0
p.Q228Q c.684 G>A 0 0 0 0 0 0.12 0 0
p.P230L c.689 C>T 0 0 0 0 0.31 0 0 0
p.P230P c.690 G>A 0 0 0 0 0.08 0 0 0
p.Q233Q c.699 G>A 0 0 0 0 0 0.36 0.19 0
p.A240A c.720 T>C 0 0 0 0 0 0 0.19 0
p.T242T c.726 C>T 0 0 0 0 0 0.12 0 0
p.G248V c.743 G>T 0 0 0 0 0 0.06 0 0
p.H260P c.779 A>C 0 0 0 0 0.23 0 0 0
p.I264I c.792 C>T 0 0 0 0 0.15 0 0 0
p.V265V c.795 C>G 0 1.28 0 0 0 0 0 0
p.C273C c.819 C>T 0 0.43 0 0 0 0 0 0
p.K278E c.832 A>G 0 0 0 0 0.23 0.24 0 0
p.N279K c.837 C>A 0 0 0 0 0 0.06 0 0
p.D294H c.880 G>C 0.01 0 0 0 1 1.43 2.45 0
p.F300F c.900 C>T 0 2.99 0 0 0 0 0 0
p.T308M c.923 C>T 0 0 0 0 0 0.06 0 0
p.T314T c.942 A>G 0.09 44.44 13.27 13.21 7.69 2.33 10.75 18.75
Abbreviations: SoEur, Southern Europe, NoEur, Northern Europe, PNG, Papua New Guinea, US, United States. Allele frequency % were rounded 
to two decimal places, therefore, rare alleles may be reported as zero due to rounding.BMC Genetics 2008, 9:31 http://www.biomedcentral.com/1471-2156/9/31
Page 4 of 8
(page number not for citation purposes)
Nucleotide diversity was also calculated for NS SNPs only
to further understand the contribution of these SNPs to
MC1R genetic variation (Table 3). π in NS SNPs ranged
from a low of 0.6 × 10-4 in subjects from Africa to a high
of 9.0 × 10-4 in the US. Within the European populations,
π for NS SNPs was the greatest in Britain (10.9 × 10-4). As
was seen for all SNPs, θ for NS SNPs was the highest in
Italy (36.6 × 10-4).
In addition to a high degree of inter-population variabil-
ity, MC1R has a higher degree of nucleotide diversity in
comparison to other groups of genes (Table 4). Studies of
genetic variation in various gene groups, e.g., genes
important in telomere biology [33], antigen processing
and presenting genes [34], pharmaceutical response [35],
and environmental response genes [36], showed π values
ranging from 3.0 × 10-4 to 6.7 × 10-4, while all seven pop-
ulations studied for MC1R had a combined π value of
10.1 × 10-4. θ showed similarly higher values in MC1R
(64.2 × 10-4) than in other sets of genes (all <8.4 × 10-4).
Population Differentiation
The FST statistic, a pairwise measure of population differ-
entiation, has been used extensively to compare the
degrees of heterozygosity across populations[2,37]. There-
fore, MC1R FST was calculated for each of the described
populations (Table 5). Overall, a very high degree of dif-
ferentiation was noted between Asia and each of the other
groups; FST ranged from 0.459 between Asia and Africa to
0.356 between Asia and the United States.
The degree of differentiation between subjects from Africa
and the six other groups ranged from 0.101 (Papua New
Guinea) to 0.232 (Southern Europe). Papua New Guinea
had relatively modest degrees of population differentia-
tion when compared to all populations except Asia, where
Table 3: MC1R nucleotide diversity, Tajima's D, and Fu's FS statistic for seven populations Statistically significant values are bolded. 
π × 10-4 θ × 10-4




Fu's FS Fu's FS p-value
Africa 11 3 7.6 0.6 19.2 5.2 -1.41 0.048 -0.24 0.436
India 3 2 3.6 1.2 6.0 4.0 -0.72 0.27 -1.27 0.202
SoEur 36 29 6.7 6.0 47.3 38.1 -2.13 <0.001 -27.92 <0.001
Greece 12 10 5.3 4.2 20.0 16.7 -1.71 0.008 -3.81 0.071
Italy 31 26 7.1 6.8 43.6 36.6 -2.10 <0.001 -6.46 0.055
Spain 17 15 6.7 5.4 27.5 24.2 -1.85 0.003 -8.44 0.009
NoEur 21 18 9.6 8.1 28.5 24.4 -1.53 0.026 -23.66 <0.001
Britain 10 10 18.1 10.9 10.9 18.1 -0.94 0.181 -2.07 0.207
France 12 10 9.4 7.4 19.7 16.4 -1.20 0.099 -2.92 0.131
Netherlands 16 14 9.3 7.6 23.3 20.4 -1.36 0.047 -4.74 0.095
US 14 10 11.1 9.0 21.5 15.4 -1.10 0.126 -2.41 0.212
Asia 6 5 9.4 7.0 8.9 7.4 1.05 0.855 2.15 0.839
PNG 4 2 7.2 1.8 8.5 4.2 -0.33 0.433 -0.78 0.301
Abbreviations: SNPs, single nucleotide polymorphisms; NS, nonsynonymous; SoEur, Southern Europe; NoEur, Northern Europe; PNG, Papua New 
Guinea; US, United States
Table 4: Comparison of MC1R nucleotide diversity and Tajima's D statistic to other sets of genes. These data include subjects from 
different ethnic groups calculated as a whole. The number of genes evaluated is shown in parentheses.
π × 10-4 θ × 10-4 # NS/kbp #S/kbp Tajima's D statistic
MC1R 10.1 64.2 38.9 18.9 -2.08
Telomere biology genesa (n = 7) 3.0 5.5 0.59 1.01 -1.365
Nuclear hormone receptor genesb (n = 40) 4.1 7.5 1.55 1.97 ND
Antigen processing and presenting genesb (n = 72) 4.7 8.3 2.29 1.99 ND
Reference genesb (n = 4950) 4.8 7.9 1.88 1.86 ND
Pharmaceutical Response genesc (n = 1598) 5.6 ND ND ND negative
Environmental response genesd (n = 213) 6.7 ND ND ND ND
aSavage et al. [2005].
bPungliya et al. [2004].
cSchneider et al. [2003].
dLivingston et al. [2004].
Abbreviations: NS, nonsynonymous, S, synonymous, ND, not determined in the reference manuscript.BMC Genetics 2008, 9:31 http://www.biomedcentral.com/1471-2156/9/31
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it was very large. The least amount of population differen-
tiation was found in comparisons between the United
States, Northern Europe, and Southern Europe.
We also performed analyses on the subpopulations that
comprised the Northern Europe (Britain, the Netherlands,
and France) and the Southern Europe (Greece, Italy, and
Spain) groups. FST values for all of these comparisons were
between 0 and 0.03, suggestive of little differentiation
(data not shown).
Selection
Several studies have identified signals of positive selection
in pigmentation genes in subjects from East Asia, and
Europe but not from those in Africa[2,38,39]. Whether or
not positive selection is present at the MC1R locus, is an
area of active investigation. Previous work suggested that
the high degree of variation in MC1R is not due to selec-
tion but rather to a relaxation of functional constraint out-
side of Africa [25]. In order to further test this hypothesis
we first determined Tajima's D statistic, a measure of the
relationship between the number of segregating sites
(SNPs) and nucleotide diversity (Table 3). It was not sta-
tistically significant (p > 0.05) in the populations from
India, Asia, Papua New Guinea, and the United States, in
which Tajima's D values were -0.72, 1.05, -0.33, and -
1.10, respectively. The African population studied had
Tajima's D value of -1.41 and a p-value of 0.048. Statisti-
cally significant and negative Tajima's D values were
present in the Southern European population (-2.13, p =
<0.001). Subgroup analyses of this population showed
the same trend, with negative Tajima's D values and p-val-
ues <0.05 in Greece, Italy, and Spain. The combined
Northern European group had a Tajima's D value of -1.53
(p = 0.026). However, only the population from the Neth-
erlands had a statistically significant Tajima's D value in
this group (-1.36, p = 0.047).
The FS test of neutrality developed by Fu (1997) and based
on θ is a powerful method to further evaluate the poly-
morphic patterns under population growth and genetic
hitchhiking. These values are shown in Table 3. Fu's FS was
statistically significant in the grouped Southern European
population (-27.92, p = <0.001) but only in the subpopu-
lation from Spain (-8.44, p = 0.009). The Northern Euro-
pean population group also had a statistically significant
FS value (-23.66, p = <0.001). The FS values were not sta-
tistically significant in the other populations. Fu and Li's
D values were comparable in scope to Tajima's D in this
study but p-values were not obtainable due to software
limitations (data not shown).
Discussion
MC1R is a small, highly variant gene. This study evaluated
the nucleotide diversity, population-specific differentia-
tion, and tested for positive selection of MC1R based on a
compilation of previously published data. We used allele
frequencies from studies that reported sequencing the
entire gene and used the 951 coding bp of MC1R as the
reference sequence. The genotype data used for these anal-
yses was derived from the sample size and reported AFs, as
a result, we were unable to assess the haplotype structure
of MC1R. Also, we could not assess the flanking sequences
of MC1R because the exact regions sequenced were not
reported in the published data.
We observed that nucleotide diversity, as measured by π
and θ, was greater in MC1R than in other groups of genes.
It should be noted that these differences may be some-
what skewed because our study evaluated only one, small
gene, MC1R, while the other studies evaluated between 7
and 4950 different genes [33-36]. Several other studies
have noted the highly polymorphic nature of MC1R
(compiled by Gerstenblith et al. [29]). Overall, the largest
degree of nucleotide diversity was seen between Asia and
all other populations, most likely due to the presence of
the R163Q (c.488 G>A) SNP, which was present in 75%
of Asians studied, versus less than 5% of any of the other
six populations. It has been suggested that this allele may
be present due to a bottleneck in Asian demographic his-
tory [25]. This allele has been shown to have reduced cell
surface expression with corresponding impairment in
cAMP coupling and effects in pigmentation [13].
The FST statistic was calculated to further assess the degree
of population-specific differentiation in MC1R. Numer-
ous population-specific SNPs and an overall high degree
of population differentiation, as measured by FST between
populations, are present in MC1R, particularly in Asians.
Minimal differentiation was noted between Southern
Europe, Northern Europe, and the United States. These
individuals were identified in previous studies as Cauca-
sian (i.e. of European descent), and likely share some
degree of common ancestry. Although frequency of spe-
cific variants differ across populations of European
descent (e.g. the allele frequency of the T allele of
c.451C>T, p.R151C, was 1.9% in Greece but 10.2% in
Britain/Ireland[29]), the sub-group analysis of the North-
Table 5: FST statistic for MC1R in seven populations.
India SoEur NoEur Asia PNG US
Africa 0.157 0.232 0.168 0.459 0.101 0.145
India 0.073 0.042 0.455 0.029 0.044
SoEur 0.016 0.437 0.089 0.017
NoEur 0.369 0.057 0.001
Asia 0.430 0.356
PNG 0.053
Abbreviations: SoEur, Southern Europe, NoEur, Northern Europe, 
PNG, Papua New Guinea, US, United States.BMC Genetics 2008, 9:31 http://www.biomedcentral.com/1471-2156/9/31
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ern and Southern European groups showed little evidence
of population differentiation. This is consistent with other
studies showing little among-population differentia-
tion[25,27,30]. The African population in this study had
moderate to large degrees of differentiation in compari-
son to other populations. This is consistent with prior
MC1R  SNP data showing fewer variants in individuals
from Africa when compared to non-African popula-
tions[29].
Tajima's D statistic tests whether or not a gene or genomic
region is evolving randomly (neutral evolution) or if the
region is under selection (non-neutral evolution). It is
based on the spectrum of AFs at different sites, as well as
on population size. Tajima's D statistic was used to test
MC1R for the presence of selection. These data, which are
based on the very large sample size described herein, sug-
gest that positive selection may be present in the Southern
European population as a whole, as well as in its three
subgroups, Greece, Italy, and Spain, based on the presence
of negative Tajima D values and statistically significant p-
values. The data also suggest the presence of some degree
of positive selection in the Northern European popula-
tion; but only the subgroup from the Netherlands had sta-
tistically significant p-values. It should be noted that
Tajima's D statistic assumes that all nucleotides are
equally mutable, subject to the same population dynam-
ics, and can be misleading if a significant population bot-
tleneck occurred. We also used Fu's FS test to address the
presence of positive selection versus neutral evolution of
MC1R. This was statistically significant only in the South-
ern and Northern European groups and the subpopula-
tion from Spain and further suggests the presence of
positive selection in the European populations. However,
our data are also limited because we were only able to
study the 951 bp of coding sequence in MC1R and were
not able to assess the larger genomic region.
Several studies have evaluated genetic adaptation of the
MC1R gene for evidence of positive selection with con-
flicting results. Some studies suggested that purifying
selection is present in Africa and that relaxation of func-
tional constraint in non-African populations, instead of
positive selection, is present[25,27,40]. On the other
hand, most recent studies have found evidence of positive
selection at other pigmentation genes. For example, Myles
et al [2] found evidence for positive selection in the DCT
gene among individuals of Chinese ancestry. In their
study, MC1R interpretations were limited because of the
different SNPs genotyped between the Perlegen and Hap-
Map data sets studied. In a study of 118 putative skin pig-
mentation genes, data were consistent with positive
selection in subjects from Europe (OCA2, TYRP1, and
KITLG) and in Asians (DCT, EGFR, and DRD2)[38].
Unfortunately, MC1R could not be evaluated in that study
due to ascertainment criteria. It was also suggested that at
least weak, recent positive selection may be present in
MC1R, based on the AF variability between CEPH Utah
and East Asian HapMap samples[3]. Our data suggest that
MC1R may be under positive selection in some popula-
tions, although additional studies are needed to further
evaluate this finding.
Conclusion
This study further quantifies the degree of MC1R genetic
variation, illustrates the complexity of this variation
across numerous populations, and suggests that positive
selection plays a role in European populations. Under-
standing of population-specific genetic variation in MC1R
and the role it plays not just in skin pigmentation, but sun
sensitivity and melanoma risk, has the potential to impact
clinical care and public health.
Methods
AF data of MC1R  SNPs from populations around the
world were compiled as described [29], from twenty-two
skin cancer case-control and population studies that fully
sequenced MC1R in distinct populations. From the stud-
ies included in Gerstenblith et al [29], we restricted our
analyses to those that included data from healthy, control
individuals [7,8,16,18,19,21,22,25,27,40-47]. We
excluded studies that noted only the presence of a SNP but
not actual AFs [4,48,49], that measured AFs on family
members [4,9,18], that were restricted to the extremes of
hair and skin color phenotypes [6], or to ethnically diverse
groups in which it was not possible to determine the AFs
for each ethnic group [17]. In addition, the study of MC1R
variants in individuals from Spain was also included [22].
Populations from Europe and the United States were
identified as Caucasian individuals in these studies. Euro-
pean populations were combined based on geographic
locations. Northern Europe consisted on subjects from
Britain, France, and the Netherlands. Southern Europe
consisted of subjects from Greece, Italy, and Spain. The
populations and studies from which they were derived are
shown in Table 1.
Genotype data files were created from AFs for each popu-
lation (Table 2) and were then analyzed in DNAsp version
4.0 [50]. The 951 base pairs (bp) of coding MC1R
sequence (NM_002386) was used as the template. Since
data files were created from AFs, we were unable to assess
the haplotype structure of MC1R. Analyses were per-
formed that were not dependent on haplotype structure.
Nucleotide diversity (π), the average number of nucle-
otide substitutions per site between two sequences, was
calculated with the Jukes and Cantor correction [51].
Theta (θ), the population mutation parameter (two times
the mutation rate per site per generation times the
number of heritable units in the population), was calcu-BMC Genetics 2008, 9:31 http://www.biomedcentral.com/1471-2156/9/31
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lated on a base pair basis from the total number of segre-
gating sites (SNPs) under the no recombination model
[52]. Genetic differentiation among populations was
measured by FST[53]. Arlequin (v3.11) was used to deter-
mine Tajima's D statistic and Fu's FS test[54] under a neu-
tral model with 1000 simulations [55,56]. Other genes
and corresponding estimates of population differentia-
tion were selected for comparison with MC1R values [33-
36].
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